Preventing misidentification of 25I-NBOH as 2C-I on routine GC-MS analyses

被引:27
作者
Coelho Neto, Jose [1 ,2 ]
Andrade, Ana Flavia B. [3 ,5 ]
Lordeiro, Rogerio Araujo [1 ]
Machado, Yuri [1 ,4 ]
Elie, Mathieu [5 ]
Ferrari Junior, Ettore [3 ]
Arantes, Luciano Chaves [3 ]
机构
[1] Inst Criminalist Policia Civil Minas Gerais, Div Lab, Secao Tecn Fis & Quim Legal, Rua Juiz de Fora 400, BR-30180060 Belo Horizonte, MG, Brazil
[2] Pontificia Univ Catolica Minas Gerais, Dept Fis & Quim, Inst Ciencias Exatas & Informat, Ave Dom Jose Gaspar 500, BR-30535901 Belo Horizonte, MG, Brazil
[3] SPO, Policia Civil Dist Fed, Secao Pericias & Anal Labs, Inst Criminalist, Lote 23,Bloco E, BR-70610200 Brasilia, DF, Brazil
[4] Univ Fed Minas Gerais, Dept Quim, Inst Ciencias Exatas, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil
[5] Univ Lincoln, Sch Chem, Brayford Pool LN6 7TS, Lincoln, England
关键词
25I-NBOH; 2C-I; NPS; Misidentification; Thermal degradation; GC-MS; NBOME; DRUGS;
D O I
10.1007/s11419-017-0362-0
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
25I-NBOH is a novel psychoactive substance (NPS) recently reported to have been found on blotter paper samples seized on the streets of Brazil, and used as a replacement for the NBOMes now scheduled in many countries. The presence of this NPS on the street market may go undetected, because the most widely and routinely utilised analytical technique for drug sample analyses is gas chromatography-mass spectrometry (GC-MS), which can misidentify 25I-NBOH (and indeed the other members of the NBOH series), because of its degradation into 2C-I (and corresponding 2C for the other members of the series) within the injector, unless a derivatization procedure is employed, which is often non-standard. While direct detection of 25I-NBOH under routine GC-MS conditions is still achieved, a slight adjustment in the standard GC-MS method, including shortening of the solvent delay window, was found to enable the detection of an additional peak due to 25I-NBOH degradation. Consequently, the presence of this secondary early chromatographic peak allowed for the distinction between 25I-NBOH and 2C-I using routine GC-MS without resorting to derivatization (or other analytical processes), thus preventing misidentification of 25I-NBOH as 2C-I.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 15 条
[1]  
[Anonymous], 2016, World drug report
[2]  
[Anonymous], 2016, 251 NBOH EUR PROJ RE
[3]   25I-NBOH: a new potent serotonin 5-HT2A receptor agonist identified in blotter paper seizures in Brazil [J].
Arantes, Luciano Chaves ;
Ferrari Junior, Ettore ;
de Souza, Luciano Figueiredo ;
Cardoso, Andriele Costa ;
Fernandes Alcantara, Thaynara Lino ;
Liao, Luciano Morais ;
Machado, Yuri ;
Lordeiro, Rogerio Araujo ;
Coelho Neto, Jose ;
Andrade, Ana Flavia B. .
FORENSIC TOXICOLOGY, 2017, 35 (02) :408-414
[4]   Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists [J].
Braden, Michael R. ;
Parrish, Jason C. ;
Naylor, John C. ;
Nichols, David E. .
MOLECULAR PHARMACOLOGY, 2006, 70 (06) :1956-1964
[5]   NBOMe - a very different kettle of fish ... [J].
Caldicott, David G. E. ;
Bright, Stephen J. ;
Barratt, Monica J. .
MEDICAL JOURNAL OF AUSTRALIA, 2013, 199 (05) :322-323
[6]  
Cayman Chemical, 2016, CAYM SPECTR LIB CSL
[7]   Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice [J].
Fantegrossi, William E. ;
Gray, Bradley W. ;
Bailey, Jessica M. ;
Smith, Douglas A. ;
Hansen, Martin ;
Kristensen, Jesper L. .
PSYCHOPHARMACOLOGY, 2015, 232 (06) :1039-1047
[8]   The NBOMe Series: A Novel, Dangerous Group of Hallucinogenic Drugs [J].
Ninnemann, Andrew ;
Stuart, Gregory L. .
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2013, 74 (06) :977-978
[9]   Receptor interaction profiles of novel N-2-methoxybenzyl (NSOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs) [J].
Rickli, Anna ;
Luethi, Dino ;
Reinisch, Julian ;
Buchy, Daniele ;
Hoener, Marius C. ;
Liechti, Matthias E. .
NEUROPHARMACOLOGY, 2015, 99 :546-553
[10]  
Scientific Working Group for the Analysis of Seized Drugs, 2016, SWGDRUG REC VERS 7 1